Sheri Miraglia
Papers
1
Total Citations
67
H-Index
1
About
Sheri Miraglia is a pioneering figure in the development of high-throughput screening (HTS) technologies, with a particular focus on fluorometric microvolume assay techniques. Her most cited work, "Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology" (1999), has garnered 67 citations and stands as a foundational contribution to the field. This paper introduced innovative homogeneous assay formats that enabled rapid, miniaturized screening of biological interactions, significantly reducing reagent consumption and increasing throughput. Miraglia’s research bridged the gap between cell-based and bead-based assays, offering versatile tools for drug discovery and molecular biology. Her work has had a lasting impact on the efficiency and scalability of HTS platforms, influencing subsequent generations of assay development. By advancing fluorometric microvolume technology, she empowered researchers to conduct sensitive, high-volume analyses with minimal sample volumes, a critical advantage in early-stage pharmaceutical research. Miraglia’s contributions remain essential reading for scientists seeking to optimize screening workflows and accelerate the identification of therapeutic candidates.
Research Focus
Key Achievements
Top Papers
- 1